HomeCompareSBTX vs O

SBTX vs O: Dividend Comparison 2026

SBTX yields 34.07% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBTX wins by $132.7K in total portfolio value
10 years
SBTX
SBTX
● Live price
34.07%
Share price
$5.87
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$24,647.82
Full SBTX calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — SBTX vs O

📍 SBTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBTXO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBTX + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBTX pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBTX
Annual income on $10K today (after 15% tax)
$2,896.08/yr
After 10yr DRIP, annual income (after tax)
$20,950.65/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, SBTX beats the other by $16,613.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBTX + O for your $10,000?

SBTX: 50%O: 50%
100% O50/50100% SBTX
Portfolio after 10yr
$100.6K
Annual income
$14,875.28/yr
Blended yield
14.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

SBTX
Analyst Ratings
5
Hold
Consensus: Hold
Altman Z
-0.3
Piotroski
1/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBTX buys
0
O buys
0
No recent congressional trades found for SBTX or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBTXO
Forward yield34.07%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$167.0K$34.2K
Annual income after 10y$24,647.82$5,102.74
Total dividends collected$119.3K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: SBTX vs O ($10,000, DRIP)

YearSBTX PortfolioSBTX Income/yrO PortfolioO Income/yrGap
1← crossover$14,107$3,407.16$10,818$608.16+$3.3KSBTX
2$19,587$4,492.08$11,787$741.68+$7.8KSBTX
3$26,787$5,828.90$12,946$911.00+$13.8KSBTX
4$36,112$7,450.06$14,345$1,127.94+$21.8KSBTX
5$48,026$9,386.56$16,056$1,409.05+$32.0KSBTX
6$63,055$11,666.79$18,171$1,777.83+$44.9KSBTX
7$81,784$14,315.54$20,820$2,268.21+$61.0KSBTX
8$104,862$17,353.02$24,188$2,929.90+$80.7KSBTX
9$132,997$20,794.11$28,533$3,837.11+$104.5KSBTX
10$166,954$24,647.82$34,235$5,102.74+$132.7KSBTX

SBTX vs O: Complete Analysis 2026

SBTXStock

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Full SBTX Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this SBTX vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBTX vs SCHDSBTX vs JEPISBTX vs KOSBTX vs MAINSBTX vs STAGSBTX vs ADCSBTX vs NNNSBTX vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.